Blomma | $5,000,000 | (May 1, 2026)
TIES | $1,500,000 | (Apr 30, 2026)
Certifyde | $2,000,000 | (Apr 30, 2026)
Certified by Founder
Lodge
Carmot Therapeutics, Inc.
start up
United States
- Berkeley
- 26/07/2022
- Series D
- $160,000,000
Carmot Therapeutics, Inc. is a clinical-stage company dedicated to the discovery and development of innovative medicines. Carmot applies a transformative, patented drug discovery approach, Chemotype Evolution to explore novel frontiers of chemistry and biology. Using Chemotype Evolution, Carmot has developed a portfolio of drug candidates in metabolic disease and oncology.
- Industry Biotechnology Research
- Website https://carmot-therapeutics.us/contact-us/
- LinkedIn https://www.linkedin.com/company/carmot-therapeutics-inc/
Skyfire | AI | $11,000,000 | (Apr 30, 2026)
General Analysis | $10,000,000 | (Apr 30, 2026)
Parallel Web Systems | $100,000,000 | (Apr 30, 2026)
Fence | $20,000,000 | (Apr 30, 2026)
Tacalyx GmbH | $12,843,270 | (Apr 30, 2026)
OpenObserve | $10,000,000 | (Apr 30, 2026)
Crazy Mountain | $15,000,000 | (Apr 30, 2026)
Windmill(US) | $12,000,000 | (Apr 29, 2026)
Lighthouse Pharmaceuticals | $12,000,000 | (Apr 29, 2026)